#nasdaq:eigr

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Files An 8-K Entry into a Material Definitive Agreement

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Files An 8-K Entry into a Material Definitive AgreementItem 1.01        Entry into a Material Definitive Agreement. On December 30, 2016, Eiger BioPharmaceuticals, Inc. (the “Company”) and its domestic subsidiaries (together with the Company, the “Borrower”) entered into a Loan and Security Agreement (the “Loan Agreement”) with Oxford Finance LLC, as…